One study showed that IL-33R expression in intestinal Treg cells improves their function and since RORγt-deficient Treg cells express higher levels of IL-33R, absence of RORγt results in less severe GvHD (250, 279). This evidence concerns the gene IL1RL1 and graft versus host disease.